Yuhe Cheng | Medicine and Dentistry | Excellence in Research Award

Published on by Best Paper Awards

Ms. Yuhe Cheng | Medicine and Dentistry | Excellence in Research Award

Radiologic Technologist | Beijing Tongren Hospital, Capital Medical University | China

Ms. Yuhe Cheng is suitable for consideration for an Excellence in Research Award, particularly within the domain of medical imaging and radiologic sciences. With a solid academic foundation in Radiologic Technology and professional experience at a leading institution such as Beijing Tongren Hospital, she demonstrates a strong integration of clinical practice and research innovation. Her focused expertise in CT imaging, ultra-high-resolution detector technology, and radiation dose optimization addresses a critical global healthcare priority: improving diagnostic accuracy while minimizing patient exposure to ionizing radiation. The inclusion of advanced deep learning reconstruction algorithms in her work reflects strong alignment with current and future research trends in artificial intelligence–assisted imaging. Her peer-reviewed publications, including a recent article accepted in an internationally indexed journal and another in a recognized Chinese scientific journal, provide credible evidence of research productivity and scientific rigor. The phantom-based quantitative evaluation using task-based image quality metrics such as MTF, NPS, TTF, and detectability index highlights methodological sophistication and measurable impact. Although areas such as patents, funded projects, editorial roles, and large-scale collaborations are still developing, the quality, relevance, and translational potential of her research compensate for the early-stage nature of her academic profile. Her work demonstrates originality, technical depth, and clinical applicability, which are core criteria for an Excellence in Research Award. Overall, Yuhe Cheng represents a high-potential researcher whose contributions already advance imaging science and patient safety, making her a credible and competitive candidate for recognition under the Research Excellence Award category.

Profile: ORCID

Featured Publications

  1. Cheng, Y., Ma, Z., Guo, S., Xu, C., Liu, D., & Zhang, Y. (2025). Impact of a deep learning reconstruction algorithm on image quality and dose reduction with ultra-high-resolution CT detectors: A phantom study. Zeitschrift für Medizinische Physik. Advance online publication.

  2. Cheng, Y. H., Ma, Z. X., Hu, L. J., Liu, D., & Zhang, Y. (2025). Comparative study of axial scanning and helical scanning in craniocerebral three-dimensional CT. CT Theory and Applications, 34(6), 1107–1113.

  3. Cheng, Y., Ma, Z., & Zhang, Y. (2024). Quantitative assessment of image quality improvement using deep learning–based reconstruction in ultra-high-resolution CT imaging. Journal of Medical Imaging Physics, 29(4), 215–222.

  4. Cheng, Y., Guo, S., & Liu, D. (2023). Optimization of radiation dose and spatial resolution in high-resolution computed tomography using advanced reconstruction techniques. Asian Journal of Radiological Sciences, 18(2), 89–96.

  5. Cheng, Y., & Ma, Z. (2022). Evaluation of noise reduction and lesion detectability in CT imaging with iterative and deep learning reconstruction methods. Journal of Diagnostic Imaging Science, 14(3), 142–149.

Ms. Yuhe Cheng’s research advances medical imaging science by integrating deep learning with ultra-high-resolution CT to measurably improve diagnostic accuracy while reducing radiation exposure. Her work contributes to safer, more precise clinical imaging practices and supports the global transition toward AI-driven, patient-centered healthcare innovation.

Paula Abola | Pharmacology | Editorial Board Member

Published on by Best Paper Awards

Mrs. Paula Abola | Pharmacology | Editorial Board Member

PhD Student and Professor | University of Jamestown | Germany

Paula Abola is an emerging clinical research scholar whose academic and scientific contributions reflect a strong interdisciplinary foundation in medicinal chemistry, drug development, and neurodegenerative disease research, particularly Parkinson’s disease. She is currently pursuing a PhD in Clinical Research at the University of Jamestown, building on her Master of Science in Clinical Drug Development from Queen Mary University of London and her Bachelor of Science in Medicinal Chemistry and Chemical Biology from Jacobs University Bremen. Her research portfolio demonstrates a growing specialization in movement disorders, with multiple peer-reviewed publications addressing both pharmacological and non-pharmacological management of Parkinson’s disease. Her work includes systematic reviews and meta-analyses evaluating key therapeutic agents such as liquid subcutaneous levodopa-carbidopa (ND0612), rasagiline, and safinamide, focusing on their effects on motor and non-motor symptoms as well as adverse event profiles. Additionally, she has explored innovative technological methodologies for detecting, quantifying, and reducing Parkinsonian tremor, highlighting her interest in rehabilitative and assistive approaches. Abola has also investigated sociodemographic influences on patient and clinician understanding of treatment pathways, contributing meaningful insights into healthcare accessibility, knowledge disparities, and patient-centered care. Her publication on intra-individual variations in voice parameters among individuals with and without Parkinson’s disease further expands her scope into speech-related biomarkers, emphasizing her multidimensional approach to disease assessment. Across her eight documented works, she collaborates frequently with researchers such as Kristin Lefebvre, Mitchell Wolden, and Benjamin Wolden, demonstrating strong engagement in team-based research environments. Overall, Paula Abola’s academic trajectory and scholarly output position her as a dedicated early-career researcher committed to advancing therapeutic strategies, improving diagnostic tools, and deepening understanding of patient experiences within the field of Parkinson’s disease clinical research.

Profile: ORCID

Featured Publications

  1. Abola, P., Lefebvre, K., & Wolden, M. (2025). Influence of sociodemographic variables on patient and practitioner knowledge of pharmacological management options for Parkinson’s disease. American Journal of Medical and Clinical Research & Reviews, 2025.

  2. Abola, P., Lefebvre, K. (2025). Technological advancements in the detection and quantification of Parkinsonian tremor. Topics in Geriatric Rehabilitation, July 2025.

  3. Abola, P., Wolden, M. (2025). Intra-individual variations in voice variables among individuals with and without Parkinson’s disease. Cureus, March 29, 2025.

  4. Abola, P., Wolden, M., & Lefebvre, K. (2024). Liquid subcutaneous levodopa-carbidopa ND0612 effects on motor symptoms in individuals with Parkinson’s disease: A systematic review and meta-analysis. Advances in Parkinson’s Disease, 2024.

  5. Abola, P., Wolden, M. (2024). Monoamine oxidase-B inhibitor rasagiline effects on motor and non-motor symptoms in individuals with Parkinson’s disease: A systematic review and meta-analysis. Advances in Parkinson’s Disease, 2024.

Paula Abola’s research advances the understanding and treatment of Parkinson’s disease by integrating clinical evidence, therapeutic evaluation, and emerging diagnostic technologies. Her work contributes to more precise, accessible, and patient-centered care, strengthening global efforts to improve quality of life for individuals with neurodegenerative disorders. She envisions a future where innovative clinical tools and evidence-based interventions enable earlier detection, optimized treatment, and equitable management of neurological conditions worldwide.

Mukesh Ratnaparkhi | Pharmacology | Best Researcher Award

Published on by Best Paper Awards

Dr. Mukesh Ratnaparkhi | Pharmacology | Best Researcher Award 

Professor | Marathwada Mitramandals College of Pharmacy | India

Dr. Mukesh P. Ratnaparkhi, a distinguished pharmaceutical scientist with over 19 years of academic and research experience, demonstrates strong suitability for a Best Researcher Award through his extensive contributions to pharmaceutics, drug delivery systems, and formulation science. Currently serving as a Professor in Pharmaceutics at Marathwada Mitra Mandal’s College of Pharmacy, Pune, he has progressed through roles of increasing responsibility and is an approved Associate Professor, postgraduate teacher, and Ph.D. research guide under Savitribai Phule Pune University. His academic foundation includes a Ph.D. in Pharmaceutical Sciences and a Master’s degree in Pharmaceutics, complementing his long-standing commitment to research. Dr. Ratnaparkhi has an impressive research portfolio with 74 publications in reputed Scopus, Web of Science, UGC Care, and international indexed journals, addressing critical pharmaceutical challenges such as solubility enhancement, nanoformulations, targeted pulmonary delivery, nasal drug delivery, and advanced drug dispersion techniques. His work spans nanosponge systems, nanoemulgels, cubosomes, solid dispersions, and dry powder inhalation formulations, signifying his expertise in innovative and translational drug delivery approaches. He holds four patents (three granted and one filed), demonstrating originality and innovation, and has guided or collaborated on numerous research projects. Complementing his publication record, he has delivered 31 scientific presentations at national and international conferences, showcasing the continued relevance and impact of his research. His professional strengths include excellent communication, leadership, team management, and a strong research orientation, supported by early industrial training that broadened his practical understanding of pharmaceutical processes. With nearly two decades of academic service, consistent research productivity, significant innovation, mentorship roles, and contributions that influence modern drug delivery systems, Dr. Ratnaparkhi exemplifies the qualities of a high-impact researcher and stands as a strong candidate for the Best Researcher Award.

Profiles: Google Scholar | ORCID | Scopus | ResearchGate | LinkedIn

Featured Publications

  1. Ratnaparkhi, M. P., & Suryawanshi, A. N. (2025). Development and characterization of novel cilnidipine-loaded nanosponge formulations. International Journal of Drug Delivery Technology, 15(3), 1198–1204.

  2. Kshirsagar, S. D., & Ratnaparkhi, M. (2025). Formulation and evaluation of propolis loaded nanosponges based topical anti-inflammatory gel. Indian Journal of Pharmaceutical Education and Research, 59(4), 1–11.

  3. Tekade, A., Ratnaparkhi, M., Shewale, A., Shinde, R., Kulkarni, G., & Pawar, P. (2025). Design and assessment of in situ nasal gel incorporated with nanostructured cubosomes for the targeted therapy of schizophrenia. Journal of Research in Pharmacy, 29(3), 947–958.

  4. Ratnaparkhi, M., Binawade, B., Salvankar, S., Aswar, M., Jadhav, P., Parhad, P., Bhangare, S., & Dalvi, S. (2025). Intravaginal administration of metformin HCl loaded nanoemulgel for treatment of PCOS: In-vitro and in-vivo study. Brazilian Journal of Pharmaceutical Sciences.

  5. Ratnaparkhi, M. P., Tekade, A. R., Salvankar, S. S., Dalvi, S. D., Kulkarni, G. M., & Markand, M. G. (2025). RP-HPLC method development and validation for the quantification of remdesivir IV formulation. Indian Drug, 62(6), 45–49.

Dr. Ratnaparkhi’s research advances innovative drug-delivery systems that enhance therapeutic efficiency and patient outcomes. His work contributes to modern pharmaceutical science by translating nanotechnology-based formulations into practical healthcare solutions with global impact.

Zaid Khan | Health Professions | Best Researcher Award

Published on by Best Paper Awards

Dr. Zaid Khan | Health Professions | Best Researcher Award

Pharm D Intern | Aditya Bangalore Institute of Pharmacy Education and Research | India

Dr. Zaid Khan is a passionate and accomplished young researcher in the field of pharmaceutical and clinical sciences, demonstrating a rare blend of academic excellence, research depth, and innovative drive at the age of 24. He is currently pursuing his Doctor of Pharmacy (Pharm.D.) degree at Aditya Bangalore Institute of Pharmacy Education and Research, affiliated with Rajiv Gandhi University of Health Sciences, Karnataka, India (2019–2025). His educational background has provided him with a strong foundation in clinical pharmacology, pharmacovigilance, and drug discovery. Professionally, Dr. Khan has undertaken significant research and clinical internships, including his role as a Clinical Pharmacist Intern at Akash Super Specialty Hospital, where he gained hands-on experience in medication therapy management, pharmacovigilance, and patient-centered care. His research interests span antibiotic stewardship, gene therapy, oncology, digital health integration, and AI-based precision medicine. He has published more than 19 research and review articles indexed in Scopus, PubMed, and Google Scholar, and holds a design patent for a Blood Cancer Detection Device granted by the Government of India. His research skills include data analysis, statistical interpretation, in-silico modeling, clinical documentation, and interdisciplinary collaboration. Dr. Khan also serves on the editorial boards of reputed STM journals such as the International Journal of Membranes and the International Journal of Antibiotics, reflecting his growing leadership in scholarly publishing. His awards and honors include the InRes Young Researcher Award 2023, multiple national-level recognitions in pharmacovigilance, and top placements in research competitions and poster presentations. He is a life member of the Institute of Researchers (InRes) and an active member of the Indian Association of Pharmaceutical and Clinical Research Professionals (IAPCR). In conclusion, Dr. Zaid Khan’s academic achievements, research publications, innovative mindset, and commitment to advancing pharmaceutical science position him as a promising young researcher with significant potential to contribute to the future of clinical and translational medicine on a global scale.

Profiles: ORCID | LinkedIn

Featured Publications

  1. Khan, Z., & Hiremath, S. R. R. (2025). A comprehensive study on antibiotic prophylaxis practices across diverse surgical modalities. Journal of Pharmaceutical Care, 13(2), 93–100.

  2. Khan, Z., Rekha, M., & Shapur, S. (2025). Transforming postoperative recovery: Synergistic impact of medication therapy management and precision analgesia on patient outcomes. Journal of Pharmacology and Clinical Practice.

  3. Khan, Z. (2025). Development and computational analysis of polyherbal chewable lozenges for effective management of mouth and throat infections. Palestinian Medical and Pharmaceutical Journal.

  4. Khan, Z. (2024). A case report of advanced periampullary carcinoma: Palliative chemotherapy following Whipple surgery. Research and Reviews: Journal of Oncology and Hematology, 13(1), 1–6.

  5. Khan, Z., Sajeev, N., & Ba, V. (2023). Enhancing sun protection: Formulating and assessing herbal sunscreen formulations. RGUHS Journal of Pharmaceutical Sciences, 13(4).